Aconitum/China comp. Suppositoires

Country: Switzerland

Language: French

Source: Swissmedic (Swiss Agency for Therapeutic Products)

Active ingredient:

aconitum napellus e tubere rec. ferm 33c D2 (HAB 33c), bryonia cretica ferm 33b (HAB) D2, cinchona pubescens e cortice sicca ferm 35b D1 (HAB 35b), eucalyptus globulus e foliis rec. ferm 33d D1 (HAB 33d), eupatorium cannabinum ex herba rec. ferm 33c D1 (HAB 33c)

Available from:

WALA Schweiz AG

INN (International Name):

aconitum napellus e tubere rec. ferm 33c D2 (HAB 33c), bryonia cretica ferm 33b (HAB) D2, cinchona pubescens e cortice sicca ferm 35b D1 (HAB 35b), eucalyptus globulus e foliis rec. ferm 33d D1 (HAB 33d), eupatorium cannabinum ex herba rec. ferm 33c D1 (HAB 33c)

Pharmaceutical form:

Suppositoires

Composition:

aconitum napellus e tubere rec. ferm 33c D2 (HAB 33c) 1 mg, bryonia cretica ferm 33b (HAB) D2 1 mg, cinchona pubescens e cortice sicca ferm 35b D1 (HAB 35b) 1 mg, eucalyptus globulus e foliis rec. ferm 33d D1 (HAB 33d) 1 mg, eupatorium cannabinum ex herba rec. ferm 33c D1 (HAB 33c) 1 mg, excipiens pro suppositorio.

Class:

D

Therapeutic group:

Médicaments Anthroposophiques

Therapeutic area:

Zulassung mit reduziertem Dossier ohne Indikation nach Art. 25 Abs. 1 KPAV (SR 812.212.24)

Authorization status:

zugelassen

Authorization date:

2014-06-13